Cellectar Biosciences

(NASDAQ) CLRB

Current Price$2.69

Market Cap$11.41M

Since IPO (2011)-100%

5 Year-99%

1 Year-66%

1 Month+8%

Cellectar Biosciences Financials at a Glance

Market Cap

$11.41M

Revenue (TTM)

$0.00

Net Income (TTM)

$21.79M

EPS (TTM)

$-10.34

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$2.69

Volume

36,224.798

Open

$2.65

Price

$2.69

Volume

36,224.798

Open

$2.65

Previous Close

$2.69

Daily Range

$2.62 - $2.81

52-Week Range

$2.43 - $20.59

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$2.69

Volume

36,224.798

Open

$2.65

Previous Close

$2.69

Daily Range

$2.62 - $2.81

52-Week Range

$2.43 - $20.59

CLRB News

Cellectar Cuts Q2 Losses and Expenses

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectar Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James V. Caruso

Website

www.cellectar.com

Headquarters

Florham Park, NJ 07932, US

CLRB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-170%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.41M

Shares Outstanding

4.24M

Volume

36.22K

Avg. Volume

34.75K

Financials (TTM)

Gross Profit

$213.60K

Operating Income

$22.98M

EBITDA

$22.77M

Operating Cash Flow

$23.12M

Capital Expenditure

$5.88K

Free Cash Flow

$23.12M

Cash & ST Invst.

$13.20M

Total Debt

$409.59K

Cellectar Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$49.46K

N/A

Gross Margin

0.00%

N/A

Market Cap

$11.41M

N/A

Market Cap/Employee

$1.04M

N/A

Employees

N/A

Net Income

$5.30M

-124.8%

EBITDA

$5.64M

+55.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$12.79M

-43.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$309.40K

-24.5%

Short Term Debt

$100.19K

+18.7%

Return on Assets

-1.45%

N/A

Return on Invested Capital

-2.25%

N/A

Free Cash Flow

$4.35M

+60.4%

Operating Cash Flow

$4.34M

+60.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$5.06+5.42%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$7.83-2.25%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.80-1.06%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.46+0.00%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.77-1.79%

MBIOMustang Bio, Inc.

MBIOMustang Bio, Inc.$0.75+1.81%

LYRALyra Therapeutics, Inc.

LYRALyra Therapeutics, Inc.$0.44-11.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About CLRB

What is the current price of Cellectar Biosciences?

Cellectar Biosciences is trading at $2.69 per share.

What is the 52-week range for Cellectar Biosciences?

Over the past 52 weeks, Cellectar Biosciences has traded between $2.43 and $20.59.

How much debt does Cellectar Biosciences have?

As of the most recent reporting period, Cellectar Biosciences reported total debt of $409,586.

How much cash does Cellectar Biosciences have on hand?

Cellectar Biosciences reported $13.20M in cash and cash equivalents in its most recent financial results.

What is Cellectar Biosciences’s dividend yield?

Cellectar Biosciences does not currently have a dividend yield.

Cellectar Biosciences

Cellectar Biosciences Financials at a Glance

CLRB News

Cellectar Cuts Q2 Losses and Expenses

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cellectar Biosciences

CLRB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cellectar Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLRB

What is the current price of Cellectar Biosciences?

What is the 52-week range for Cellectar Biosciences?

How much debt does Cellectar Biosciences have?

How much cash does Cellectar Biosciences have on hand?

What is Cellectar Biosciences’s dividend yield?

Premium Investing Services